CVC Capital Partners said on 12 October 2026 that its Catalyst III fund had agreed to acquire a minority stake in Fibrotex, an Israeli maker of multispectral camouflage, in partnership with the founding Blum family.
Why CVC Capital Partners (CVC Catalyst III) is buying Fibrotex (minority stake)
CVC said the investment will support Fibrotex's continued innovation and international expansion. Its products are designed to conceal troops and equipment from the naked eye as well as thermal cameras, night-vision devices and radar.
Deal terms and financing
CVC did not disclose financial terms. Israeli business daily Calcalist reported that CVC is buying 40% for about US$350m, with the Blum family retaining 60%.
Regulatory approvals and timing
The transaction is subject to customary regulatory approvals and is expected to complete in the first half of 2027.
Market context
Fibrotex has principal locations in Petah Tikva, Israel, and Kentucky, US; Calcalist reported that most of its sales go to the US military.
